Koyfin Home > Directory > Health Care > Alder Biopharma > Price / Earnings (ntm)

Alder Biopharma Price / Earnings (ntm) Chart (ALDR)

Alder Biopharma annual/quarterly Price / Earnings (ntm) from 2020 to 2020. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
Other Valuation Metrics:
  • Alder Biopharma Market Cap for the quarter ending March 03, 2018 was $862m a 33.01% increase of 284m year over year
  • Alder Biopharma Price / Book for the quarter ending March 03, 2018 was 3.09 a 34.98% increase of 1.08 year over year
  • Alder Biopharma Enterprise Value for the quarter ending March 03, 2018 was $585m a 50.86% increase of 298m year over year
View Chart On Koyfin